000 01681 a2200445 4500
005 20250513110925.0
264 0 _c19970129
008 199701s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1997.15.1.26
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStock, W
245 0 0 _aValue of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 1997
300 _a26-36 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aBlotting, Southern
650 0 4 _aGene Rearrangement
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xgenetics
650 0 4 _aMonitoring, Physiologic
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aProspective Studies
650 0 4 _aProtein-Tyrosine Kinases
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-bcr
700 1 _aWestbrook, C A
700 1 _aPeterson, B
700 1 _aArthur, D C
700 1 _aSzatrowski, T P
700 1 _aSilver, R T
700 1 _aSher, D A
700 1 _aWu, D
700 1 _aLe Beau, M M
700 1 _aSchiffer, C A
700 1 _aBloomfield, C D
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 15
_gno. 1
_gp. 26-36
856 4 0 _uhttps://doi.org/10.1200/JCO.1997.15.1.26
_zAvailable from publisher's website
999 _c8987325
_d8987325